Global High-Priority Regulatory Events — February 23, 2026

24-02-2026

Benchmark Electronics Inc filed an 8-K on February 24, 2026, under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 covers financial statements and exhibits. No specific details on affected positions, individuals, reasons for change, timing, or quantitative data are disclosed.

24-02-2026

24-02-2026

Cohen Circle Acquisition Corp. II filed an 8-K on February 24, 2026 (AccNo: 0001213900-26-019871, Size: 288 KB), disclosing other events under Item 8.01 and financial statements and exhibits under Item 9.01, in connection with a merger/acquisition event. No specific details on deal structure, parties involved, valuation, terms, financial metrics, synergies, regulatory pathway, or shareholder impacts were explicitly stated. Sector not specified, and no quantitative data, comparisons, or scheduled events provided.

24-02-2026

24-02-2026

24-02-2026

24-02-2026

24-02-2026

24-02-2026

24-02-2026

Atomera Inc filed a Form 8-K on 2026-02-24 reporting under Item 1.01 entry into a Material Definitive Agreement, under Item 7.01 Regulation FD Disclosure, and under Item 9.01 Financial Statements and Exhibits. This multi-item filing signals a significant contractual event but provides no details on parties, terms, or financial impacts. No quantitative metrics, positive or negative changes, or period-over-period comparisons are disclosed.

• ·AccNo: 0001683168-26-001269
• ·File size: 727 KB
• ·Sector: NOT_DISCLOSED

24-02-2026

Aebi Schmidt Holding AG filed an 8-K on 2026-02-24 disclosing under Item 5.02 a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers, alongside Item 2.02 on results of operations and financial condition, and Item 9.01 on financial statements and exhibits. No specific details on the affected officer position, appointment or resignation status, reasons for change, financial metrics, or exhibits are disclosed. No quantitative data or period-over-period comparisons are provided.

24-02-2026

RF Acquisition Corp III filed an 8-K on February 24, 2026 (AccNo: 0001829126-26-001581), disclosing unregistered sales of equity securities under Item 3.02, other events under Item 8.01, and financial statements and exhibits under Item 9.01. No specific details on deal structure, parties involved, valuation, synergies, regulatory pathway, shareholder impact, or market implications are provided. No quantitative metrics, period-over-period comparisons, or scheduled events are mentioned.

24-02-2026

BANK OF HAWAII CORP filed an 8-K on 2026-02-24 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers). Item 9.01 references Financial Statements and Exhibits. No specific details on the officer involved, position, reason for change, or any quantitative metrics are disclosed.

24-02-2026

Northern Oil & Gas, Inc. filed an 8-K on 2026-02-24 disclosing entry into a material definitive agreement (Item 1.01) and completion of an acquisition or disposition of assets (Item 2.01), alongside creation of a direct financial obligation (Item 2.03) and Regulation FD disclosure (Item 7.01). No quantitative metrics, deal values, parties involved, synergies, or financial impacts are disclosed in the provided filing information. Item 9.01 references financial statements and exhibits, but specifics are NOT_DISCLOSED.

• ·AccNo: 0001193125-26-064523
• ·Filing Size: 338 KB
• ·Event Type: Merger/Acquisition

24-02-2026

Invesco Mortgage Capital Inc. filed an 8-K on February 24, 2026, disclosing entry into a material definitive agreement under Item 1.01 and termination of a material definitive agreement under Item 1.02. Item 9.01 includes financial statements and exhibits. No specific transaction values, terms, parties, financial impacts, or strategic details are disclosed.

24-02-2026

Livento Group, Inc. filed an 8-K on 2026-02-24 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for changes, timing, or any financial metrics are disclosed. Sector is not specified.

• ·AccNo: 0002063628-26-000002
• ·Filing size: 14 KB
• ·Event date: 2026-02-24
• ·Sector: not specified

24-02-2026

Pelican Acquisition Corp filed an 8-K on February 24, 2026 (AccNo: 0001829126-26-001595), disclosing information under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits related to a merger/acquisition event. No specific details on deal structure, parties, valuation, financial terms, or strategic rationale are explicitly stated in the provided filing summary. All quantitative metrics, named entities beyond the filer, and scheduled events are NOT_DISCLOSED.

24-02-2026

Archrock, Inc. filed an 8-K on 2026-02-24 under Item 5.02 disclosing a change involving departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on the key position affected, individuals involved, reasons for the change, or any financial metrics are disclosed. No quantitative data, performance comparisons, or scheduled events are mentioned.

24-02-2026

Tidewater Inc filed a Form 8-K on February 24, 2026 (AccNo: 0001104659-26-018759), reporting under Item 1.01 entry into a material definitive agreement, under Item 7.01 Regulation FD disclosure, and under Item 9.01 financial statements and exhibits. This is a multi-item filing with no specific details on the agreement, disclosures, transaction value, or financial impacts provided in the summary. No quantitative metrics, positive or negative changes, or period-over-period comparisons are disclosed.

24-02-2026

Aptose Biosciences Inc. filed a Form 8-K on 2026-02-24 disclosing under Item 1.01 entry into a material definitive agreement, under Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement, under Item 7.01 Regulation FD disclosure, and under Item 9.01 financial statements and exhibits. This is a multi-item filing with no quantitative financial metrics, transaction values, or performance comparisons provided. No positive or negative metrics are mentioned, making the disclosure purely informational.

24-02-2026

Atlantic Union Bankshares Corp filed an 8-K on February 24, 2026, under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific names, positions affected, reasons for changes, timing details, or quantitative data are provided.

24-02-2026

Protagenic Therapeutics, Inc. filed an 8-K on February 24, 2026, disclosing entry into a material definitive agreement (Item 1.01) and termination of a prior material definitive agreement (Item 1.02), alongside completion of an acquisition or disposition of assets (Item 2.01) and unregistered sales of equity securities (Item 3.02). Other events are noted under Item 8.01, with financial statements and exhibits provided under Item 9.01. No quantitative financial metrics, deal values, or specific parties are disclosed.

24-02-2026

Klotho Neurosciences, Inc. filed an 8-K on February 24, 2026, reporting under Item 1.01 entry into a material definitive agreement and under Item 9.01 financial statements and exhibits. No specific details regarding the nature of the agreement, transaction value, financial impacts, or any quantitative metrics are disclosed. No positive or negative performance metrics, comparisons, or scheduled events are mentioned.

24-02-2026

ONE Gas, Inc. filed a Form 8-K on February 24, 2026, under Item 1.01 disclosing entry into a material definitive agreement. Item 9.01 includes financial statements and exhibits. No specific transaction details, financial metrics, dollar values, or impacts are disclosed.

24-02-2026

24-02-2026

Beam Therapeutics Inc. filed a Form 8-K on February 24, 2026 (AccNo: 0001193125-26-065191), reporting under Item 1.01 entry into a material definitive agreement, Item 2.02 results of operations and financial condition, Item 2.03 creation of a direct financial obligation or an obligation under an off-balance sheet arrangement, and Item 9.01 financial statements and exhibits. This is a multi-item mandatory filing with no specific transaction details, financial metrics, dollar values, or performance comparisons disclosed. No positive or negative metrics are provided, resulting in purely informational disclosure.

24-02-2026

Advanced Micro Devices Inc filed an 8-K on February 24, 2026, reporting under Item 1.01 entry into a material definitive agreement, Item 3.02 unregistered sales of equity securities, Item 7.01 Regulation FD disclosure, and Item 9.01 financial statements and exhibits. No specific details on the agreement, transaction sizes, financial impacts, or other metrics are disclosed in the provided filing summary. This multi-item filing signals potentially significant developments but lacks quantitative or qualitative context for assessment.

24-02-2026

Xometry, Inc. filed an 8-K on 2026-02-24 disclosing an officer change under Item 5.02, which covers departures of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits are included. No specific details on the affected officer, nature of the change, reasons, timing, or compensation terms are disclosed.

24-02-2026

24-02-2026

Sotera Health Co filed an 8-K on 2026-02-24 disclosing results of operations and financial condition under Item 2.02, an officer change or appointment under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), and financial statements/exhibits under Item 9.01. Key details on the affected position, appointment/resignation status, reasons, or timing are NOT_DISCLOSED. No quantitative financial metrics, period-over-period comparisons, or other specifics are provided.

24-02-2026

First Watch Restaurant Group, Inc. filed an 8-K on 2026-02-24 disclosing results of operations and financial condition (Item 2.02), departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements (Item 5.02), Regulation FD disclosure (Item 7.01), and financial statements and exhibits (Item 9.01). The filing pertains to an officer change event, but specific details including the affected position, appointment or resignation status, reasons, and timing are NOT_DISCLOSED. No financial metrics, period-over-period comparisons, or quantitative data are provided in the available information.

24-02-2026

Thermon Group Holdings, Inc. filed a Form 8-K on 2026-02-24 under Items 1.01 (Entry into a Material Definitive Agreement), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). This is a multi-item filing representing a material event, but specific details of the agreement, transaction terms, financial impacts, or any metrics are NOT_DISCLOSED.

24-02-2026

CECO Environmental Corp filed an 8-K on 2026-02-24 reporting under Item 1.01 entry into a material definitive agreement, Item 7.01 Regulation FD Disclosure, and Item 9.01 Financial Statements and Exhibits. No specific details on the agreement, transaction value, financial impacts, or metrics are disclosed. This is a multi-item filing with no quantitative data or period-over-period comparisons provided.

24-02-2026

Willis Lease Finance Corp filed an 8-K on 2026-02-24 disclosing Item 1.01 (Entry into a Material Definitive Agreement) and Item 2.03 (Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement). No specific details on the agreement, financial terms, parties, or impacts are provided in the filing summary. No quantitative metrics, positive or negative changes, or comparisons are mentioned.

24-02-2026

24-02-2026

Twin Vee PowerCats, Co. filed an 8-K on 2026-02-24 disclosing entry into a material definitive agreement under Item 1.01, other events under Item 8.01, and financial statements and exhibits under Item 9.01. No specific details on the agreement, events, transaction value, financial impacts, or quantitative metrics are provided in the filing summary. No positive or negative performance metrics, period-over-period changes, or guidance revisions are mentioned.

• ·Multi-item 8-K filing (Items 1.01, 8.01, 9.01)
• ·Accession Number: 0001731122-26-000289
• ·File size: 669 KB

24-02-2026

FIRST HAWAIIAN, INC. filed an 8-K on February 24, 2026, under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 includes financial statements and exhibits. No specific details on affected positions, individuals, reasons for change, timing, or any quantitative impacts are disclosed.

24-02-2026

SCI Engineered Materials, Inc. filed an 8-K on 2026-02-24 under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 reports financial statements and exhibits. No specific details, names, dates, financial impacts, or directional implications (positive or negative) are provided.

24-02-2026

Kyverna Therapeutics, Inc. filed an 8-K on 2026-02-24 disclosing officer changes under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), other events under Item 8.01, and financial statements/exhibits under Item 9.01. Specific details including the key position affected, names of individuals, appointment or resignation status, reasons for change, and any quantitative data such as compensation amounts are NOT_DISCLOSED. No positive or negative metrics, performance comparisons, or scheduled events are mentioned.

24-02-2026

Bayview Acquisition Corp filed an 8-K on 2026-02-24 under Item 3.01 providing notice of delisting or failure to satisfy a continued listing rule or standard, or transfer of listing, in the context of a merger/acquisition event. No quantitative data, deal terms, financial metrics, parties involved, or other specific details are disclosed. Sector is not specified.

24-02-2026

Inhibitor Therapeutics, Inc. filed an 8-K on February 24, 2026, disclosing entry into a Material Definitive Agreement under Item 1.01. Item 9.01 includes Financial Statements and Exhibits. No financial metrics, transaction details, or impacts are disclosed.

24-02-2026

Advantage Solutions Inc. filed a Form 8-K on 2026-02-24 reporting entry into a material definitive agreement under Item 1.01, Regulation FD disclosure under Item 7.01, and financial statements and exhibits under Item 9.01. This is a multi-item filing, but specific details of the agreement, transaction value, financial impacts, or any positive/negative metrics are NOT_DISCLOSED. No quantitative data, period-over-period comparisons, or directional indicators are provided.

24-02-2026

Modular Medical, Inc. filed an 8-K on February 24, 2026, disclosing under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or an obligation under an off-balance sheet arrangement. Item 9.01 provides financial statements and exhibits. No specific transaction details, dollar values, terms, or financial impacts are disclosed.

24-02-2026

Golden Matrix Group, Inc. filed an 8-K on 2026-02-24 under Item 5.02 disclosing a change involving departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for change, or any quantitative data such as compensation amounts are disclosed in the provided filing information. No positive or negative metrics are mentioned.

24-02-2026

Playboy, Inc. filed an 8-K on February 24, 2026, disclosing an officer change under Item 5.02, which covers departures of directors or certain officers, elections of directors, appointments of certain officers, or compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included with the filing. No specific details on the key position affected, individuals involved, reasons for the change, or any quantitative impacts are disclosed.

24-02-2026

EQV Ventures Acquisition Corp. filed an 8-K on 2026-02-24 disclosing entry into a material definitive agreement under Item 1.01, likely related to a merger/acquisition, along with unregistered sales of equity securities (Item 3.02), other events (Item 8.01), and financial statements/exhibits (Item 9.01). No specific transaction parties, deal size, valuation, or financial metrics are disclosed in the provided filing summary. This appears to be a standard SPAC business combination announcement without detailed terms.

24-02-2026

Microvision, Inc. filed a multi-item Form 8-K on February 24, 2026 (AccNo: 0001493152-26-007835), reporting Item 1.01 entry into a material definitive agreement, Item 1.02 termination of a material definitive agreement, Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement, Item 3.02 unregistered sales of equity securities, Item 7.01 Regulation FD disclosure, and Item 9.01 financial statements and exhibits. No quantitative details such as transaction values, share counts, dollar amounts, percentages, or period-over-period comparisons are disclosed in the provided filing information. No positive or negative financial metrics, guidance changes, or scheduled events are mentioned.

24-02-2026

24-02-2026

INVO Fertility, Inc. filed an 8-K on 2026-02-24 disclosing entry into a material definitive agreement (Item 1.01) and completion of an acquisition or disposition of assets (Item 2.01), alongside unregistered sales of equity securities (Item 3.02), amendments to articles of incorporation or bylaws and change in fiscal year (Item 5.03), other events (Item 8.01), and financial statements/exhibits (Item 9.01). This filing signals a completed merger/acquisition transaction, but no specific parties, terms, values, or impacts are disclosed. No quantitative metrics, positive or negative changes, or performance variations are provided.

24-02-2026

SharonAI Holdings, Inc. filed a Form 8-K on 2026-02-24 reporting under Item 1.01 entry into a material definitive agreement and under Item 5.02 departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 discloses financial statements and exhibits. No specific details, numerical values, named parties, financial impacts, or other metrics are provided.

24-02-2026

Horizon Space Acquisition II Corp. filed an 8-K on 2026-02-24 disclosing entry into a material definitive agreement under Item 1.01, creation of a direct financial obligation or off-balance sheet arrangement under Item 2.03, and unregistered sales of equity securities under Item 3.02. Item 8.01 reports other events, with financial statements and exhibits under Item 9.01. No specific deal terms, financial metrics, parties involved, or performance comparisons are disclosed.

• ·AccNo: 0001929980-26-000053
• ·Filing size: 240 KB

24-02-2026

Chewy, Inc. filed an 8-K on 2026-02-24 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure (Item 7.01) and Financial Statements and Exhibits (Item 9.01). Specific details including the key position affected, names, appointment or resignation status, reasons, and timing are NOT_DISCLOSED. No quantitative data, financial metrics, or performance comparisons are provided.

24-02-2026

SENTIENT BRANDS HOLDINGS INC. filed a Form 8-K on 2026-02-24 reporting Item 1.01 (Entry into a Material Definitive Agreement), Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details on transaction values, personnel changes, events, or financial impacts disclosed in the provided information. No quantitative metrics, positive or negative changes, or period-over-period comparisons are mentioned.

24-02-2026

AB International Group Corp. filed a Form 8-K on 2026-02-24 reporting under Item 1.01 entry into a Material Definitive Agreement and under Item 9.01 Financial Statements and Exhibits. No details on the agreement, transaction value, parties involved, financial impacts, or any quantitative metrics are disclosed. This is a multi-item mandatory filing with no specified positive or negative metrics.

• ·Accession Number: 0001663577-26-000043
• ·Filing size: 492 KB
• ·Sector: NOT_DISCLOSED

24-02-2026

SunCoke Energy, Inc. filed an 8-K on 2026-02-24 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals, reasons for change, or quantitative impacts are disclosed. No positive or negative metrics, financial data, or further governance implications provided.

24-02-2026

Bravo Multinational Inc. filed an 8-K on 2026-02-24 under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details including key positions affected, individuals involved, reasons for changes, timing, or any financial metrics are disclosed. No positive or negative performance metrics are mentioned.

24-02-2026

Summit Networks Inc. filed a Form 8-K on 2026-02-24 (AccNo: 0001091818-26-000022) disclosing an officer change under Item 5.02, which covers departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. No specific details such as the key position affected, names of individuals, reasons for the change, timing, internal/external status, or board composition impacts are provided. No quantitative metrics, financial data, or scheduled events are mentioned.

24-02-2026

Yext, Inc. filed an 8-K on 2026-02-24 under Item 5.02 disclosing a change involving departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on positions affected, individuals involved, reasons for change, or any quantitative metrics are disclosed. No positive or negative performance metrics are mentioned.

24-02-2026

BCB Bancorp Inc filed an 8-K on 2026-02-24 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for changes, or any quantitative metrics are disclosed. Filing accession number 0001193125-26-066971, size 136 KB.

24-02-2026

374Water Inc. filed an 8-K on 2026-02-24 disclosing an officer change under Item 5.02, which covers departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on positions affected, individuals involved, reasons for change, or any quantitative metrics are disclosed.

24-02-2026

RCM Technologies, Inc. filed an 8-K on February 24, 2026 (AccNo: 0000929638-26-000744), reporting under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement. Item 9.01 discloses financial statements and exhibits. No specific transaction details, dollar values, parties, terms, or financial metrics are provided in the filing summary.

24-02-2026

Tectonic Therapeutic, Inc. filed an 8-K on 2026-02-24 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers). The filing also includes Regulation FD Disclosure (Item 7.01) and Financial Statements and Exhibits (Item 9.01). Specific details such as the key position affected, individual name, appointment or resignation status, reason, or timing are NOT_DISCLOSED.

24-02-2026

Climb Global Solutions, Inc. filed an 8-K on February 24, 2026 (AccNo: 0001437749-26-005335), reporting under Item 1.01 entry into a material definitive agreement, Item 7.01 Regulation FD disclosure, and Item 9.01 financial statements and exhibits. This is a multi-item filing with no specific details on the agreement, transaction terms, financial impacts, or quantitative metrics disclosed in the provided information. No positive or negative metrics, period-over-period comparisons, or guidance changes are mentioned.

24-02-2026

Finward Bancorp filed an 8-K on 2026-02-24 disclosing Item 5.02 related to departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 8.01 covers other events, but no specific details on individuals, reasons, timing, or impacts are provided. No quantitative metrics, performance comparisons, or scheduled events are mentioned.

24-02-2026

XCel Brands, Inc. filed a Form 8-K on February 24, 2026, reporting under Item 1.01 entry into a material definitive agreement and under Item 2.03 the creation of a direct financial obligation or an obligation under an off-balance sheet arrangement. Item 9.01 discloses financial statements and exhibits. No specific details, dollar values, terms, parties, or impacts are provided in the filing summary.

24-02-2026

Entrepreneur Universe Bright Group filed Form 8-K on February 24, 2026, reporting Item 3.03 (Material Modifications to Rights of Security Holders) and Item 5.03 (Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year), with Item 9.01 listing Financial Statements and Exhibits. No quantitative financial metrics, transaction values, period-over-period comparisons, or specific details on the modifications/amendments are disclosed. This is a multi-item mandatory filing focused on governance changes.

24-02-2026

ONITY GROUP INC. filed an 8-K on February 24, 2026 (AccNo: 0001493152-26-007881) under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific names, positions affected, reasons for change, timing details, numerical values, or other quantitative data are disclosed in the provided filing information.

24-02-2026

TREX CO INC filed an 8-K on 2026-02-24 disclosing matters under Item 5.02 related to departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 8.01 covers other events, and Item 9.01 lists financial statements and exhibits. No specific details on affected positions, names, reasons for change, or financial metrics are disclosed.

24-02-2026

Leggett & Platt Inc filed an 8-K on February 24, 2026, under Item 5.02 disclosing a change involving departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on positions, individuals, reasons, or financial impacts were provided.

24-02-2026

Liberty Global Ltd. filed an 8-K on February 24, 2026, disclosing under Item 1.01 entry into a material definitive agreement and under Item 2.03 the creation of a direct financial obligation or an obligation under an off-balance sheet arrangement. Item 9.01 provides for financial statements and exhibits. No quantitative details such as transaction value, financial impacts, or performance metrics are disclosed.

24-02-2026

24-02-2026

SUPERNUS PHARMACEUTICALS, INC. filed an 8-K on 2026-02-24 disclosing an officer change under Item 5.02, which covers departures of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on the affected position, individuals involved, reasons for the change, timing, or any quantitative data are disclosed.

24-02-2026

Amplitude, Inc. filed an 8-K on 2026-02-24 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). The filing also includes Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No specific details on the affected officer, position, reason for change, timing, or any quantitative metrics are disclosed.

24-02-2026

MetLife Inc filed an 8-K on February 24, 2026 (AccNo: 0001193125-26-067070), disclosing an Item 5.02 event related to the departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details including key positions affected, names, reasons for changes, timing, or any financial/quantitative impacts are disclosed. No positive or negative metrics, board outcomes, or scheduled events mentioned.

24-02-2026

Boyd Gaming Corp filed an 8-K on February 24, 2026 (AccNo: 0001193125-26-067254), disclosing an officer change under Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Specific details on the key position affected, individuals involved, appointment or resignation status, reasons for the change, and any impacts are NOT_DISCLOSED. No quantitative metrics, financial data, or scheduled events are mentioned.

24-02-2026

MIDDLESEX WATER CO filed Form 8-K on 2026-02-24 under Item 1.01 disclosing entry into a material definitive agreement. Item 9.01 includes financial statements and exhibits. No specific terms, transaction details, financial metrics, or impacts are disclosed.

24-02-2026

DENTSPLY SIRONA Inc. filed an 8-K on 2026-02-24 disclosing changes related to departure of directors or certain officers, election or appointment of directors/officers, and compensatory arrangements under Item 5.02. The filing also includes Regulation FD disclosure under Item 7.01 and financial statements/exhibits under Item 9.01. Specific details on affected positions, individuals, reasons for change, or any quantitative impacts are NOT_DISCLOSED.

24-02-2026

Unitil Corp filed an 8-K on 2026-02-24 disclosing under Item 1.01 entry into a material definitive agreement and under Item 9.01 financial statements and exhibits. No details on the agreement's nature, parties, terms, value, strategic importance, financial impacts, or any quantitative metrics are provided. This is a multi-item mandatory filing with no directional financial data disclosed.

24-02-2026

Shake Shack Inc. filed an 8-K on 2026-02-24 under Item 5.02 disclosing a matter related to Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. No specific details on positions affected, individuals involved, reasons for change, or any quantitative data such as compensation amounts are disclosed in the provided filing summary. No positive or negative metrics, scheduled events, or financial impacts are mentioned.

24-02-2026

Walt Disney Co filed an 8-K on 2026-02-24 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on individuals, positions, reasons, or quantitative impacts are disclosed.

24-02-2026

Once Upon a Farm, PBC filed a Form 8-K on February 24, 2026 (AccNo: 0001193125-26-067197), disclosing information under Item 5.02 related to Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. No specific details on affected positions, individuals involved, reasons for the change, or governance impacts are provided. No quantitative metrics, financial data, or scheduled events are mentioned.

24-02-2026

Sono Group N.V. filed a Form 8-K on February 24, 2026, disclosing under Item 1.01 entry into a material definitive agreement and under Item 3.02 unregistered sales of equity securities, with exhibits provided under Item 9.01. No specific transaction details, financial terms, dollar values, share counts, or impacts are disclosed in the provided information. This is a multi-item filing representing mandatory disclosures of potentially strategic and dilutive events.

24-02-2026

Compass Diversified Holdings filed an 8-K on February 24, 2026, reporting under Item 1.01 entry into a material definitive agreement and under Item 9.01 financial statements and exhibits. No specific details on the agreement, transaction value, financial impacts, or other metrics are disclosed in the provided filing summary. No positive or negative quantitative metrics are mentioned.

24-02-2026

CONSUMER PORTFOLIO SERVICES, INC. filed an 8-K on February 24, 2026, under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for change, timing, or impacts are disclosed in the provided filing information. Sector is not specified.

24-02-2026

Business First Bancshares, Inc. filed an 8-K on 2026-02-24 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals, reasons for change, or financial impacts are disclosed. No quantitative metrics, positive or negative changes, or performance comparisons provided.

24-02-2026

Apple Inc. filed an 8-K on February 24, 2026, reporting Item 5.07 on the submission of matters to a vote of security holders, which typically discloses results from a shareholder meeting such as director elections or compensation approvals. Item 9.01 covers financial statements and exhibits, but no specific details, outcomes, or metrics are provided. No financial impacts, vote results, or other quantitative data are disclosed.

24-02-2026

W. P. Carey Inc. filed a Form 8-K on 2026-02-24 reporting under Item 1.01 entry into a material definitive agreement, Item 8.01 other events, and Item 9.01 financial statements and exhibits. No specific details on the agreement, transaction value, parties involved, financial impacts, or metrics are disclosed in the provided filing summary. This is a multi-item filing with no quantitative data or period-over-period comparisons mentioned.

24-02-2026

UFP Technologies Inc filed an 8-K on February 24, 2026, disclosing a material cybersecurity incident under Item 1.05. No details on the incident's nature, scope, financial impact, remediation costs, or operational disruptions were provided. This mandatory disclosure highlights a significant security event but lacks quantitative metrics for assessment.

24-02-2026

Genesis Energy LP filed a multi-item Form 8-K on 2026-02-24 disclosing Item 1.01 Entry into a Material Definitive Agreement, Item 7.01 Regulation FD Disclosure, and Item 9.01 Financial Statements and Exhibits. No specific details on the core transaction, dollar values, financial impacts, or quantitative metrics are provided in the available information. All numerical data, period-over-period comparisons, and strategic implications remain NOT_DISCLOSED.

24-02-2026

Trailblazer Merger Corp I filed an 8-K on 2026-02-24 (AccNo: 0001213900-26-019945, Size: 334 KB) disclosing Item 5.07 regarding Submission of Matters to a Vote of Security Holders in connection with a Merger/Acquisition event. No specific details on vote results, parties involved, deal structure, financial terms, or metrics are provided. Sector is not specified.

24-02-2026

Bark, Inc. filed an 8-K on February 24, 2026 (AccNo: 0001628280-26-011180), disclosing an event under Item 5.02 related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for changes, timing, or any quantitative data are disclosed. Sector is not specified.

24-02-2026

Concentrix Corp filed an 8-K on 2026-02-24 reporting Item 1.01 (Entry into a Material Definitive Agreement) and Item 2.03 (Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement), with Item 9.01 providing Financial Statements and Exhibits. No specific details on the agreement, transaction value, terms, or financial impacts are disclosed. This is a multi-item mandatory filing with no quantitative metrics provided.

24-02-2026

Cardiff Oncology, Inc. filed an 8-K on 2026-02-24 announcing the completion of an acquisition or disposition of assets under Item 2.01. The filing includes financial statements and exhibits under Item 9.01. No quantitative metrics, deal details, or performance comparisons are disclosed.

24-02-2026

Ameris Bancorp filed an 8-K on February 24, 2026 (AccNo: 0000351569-26-000026, Size: 142 KB), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers). Specific details including key positions affected, individuals involved, reasons for the change, or any quantitative data are NOT_DISCLOSED. No positive or negative metrics, financial impacts, or governance implications are mentioned.

• ·Filing size: 142 KB

24-02-2026

Art Technology Acquisition Corp. filed an 8-K on 2026-02-24 under Item 5.02 disclosing matters related to departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. No specific names, dates, financial details, transaction information, or quantitative metrics are mentioned in the filing summary. No positive or negative performance indicators, scheduled events, or M&A details are provided.

24-02-2026

PALOMA ACQUISITION CORP I filed an 8-K on 2026-02-24 disclosing entry into a material definitive agreement under Item 1.01, likely related to a merger/acquisition. The filing also covers unregistered sales of equity securities (Item 3.02), departures/elections/appointments of directors/officers and compensatory arrangements (Item 5.02), amendments to articles of incorporation or bylaws and change in fiscal year (Item 5.03), other events (Item 8.01), and financial statements/exhibits (Item 9.01). No specific details on parties, structure, valuation, terms, or metrics are disclosed.

24-02-2026

Microbot Medical Inc. filed a Form 8-K on 2026-02-24 reporting entry into a material definitive agreement (Item 1.01), departure of directors or certain officers, election or appointment of directors/officers, and compensatory arrangements of certain officers (Item 5.02), along with financial statements and exhibits (Item 9.01). This is a multi-item mandatory disclosure with no specific details provided on the agreement terms, personnel involved, dollar values, or financial impacts. Filing size is 319 KB (AccNo: 0001493152-26-007900).

24-02-2026

CION Investment Corp filed an 8-K on February 24, 2026, under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals, reasons for change, or impacts are provided in the filing summary. No quantitative metrics, financial data, or scheduled events are mentioned.

24-02-2026

Fifth Third Bancorp filed an 8-K on February 24, 2026 (AccNo: 0000035527-26-000126), disclosing information under Item 5.02 regarding departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for changes, timing, or any financial metrics are provided in the available information. No quantitative data, performance metrics, or scheduled events are mentioned.

24-02-2026

Artiva Biotherapeutics, Inc. filed a Form 8-K on 2026-02-24 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals, reasons for change, or any quantitative impacts are provided in the available information. No positive or negative metrics reported.

24-02-2026

CDT Equity Inc. filed an 8-K on February 24, 2026, reporting entry into a material definitive agreement under Item 1.01 and unregistered sales of equity securities under Item 3.02, with financial statements and exhibits under Item 9.01. No specific details on the agreement, transaction size, parties involved, financial impacts, or strategic rationale are disclosed in the provided information. No quantitative metrics, period-over-period comparisons, positive or negative changes are mentioned.

24-02-2026

BuzzFeed, Inc. filed a Form 8-K on February 24, 2026, disclosing under Item 1.01 its entry into a material definitive agreement and under Item 2.03 the creation of a direct financial obligation or an obligation under an off-balance sheet arrangement of the registrant. Item 9.01 includes financial statements and exhibits. No specific transaction details, dollar values, strategic context, or financial impacts are disclosed in the provided filing summary.

24-02-2026

Rank One Computing Corp dba ROC filed an 8-K on February 24, 2026, disclosing entry into a Material Definitive Agreement under Item 1.01, Other Events under Item 8.01, and Financial Statements and Exhibits under Item 9.01. No specific details, dollar values, financial metrics, or performance comparisons (positive, negative, or flat) are disclosed in the provided filing summary. This is a multi-item mandatory filing with no quantitative impacts or strategic context provided.

24-02-2026

La Rosa Holdings Corp. filed an 8-K on 2026-02-24 disclosing an officer change or departure under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). The filing also includes Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). Specific details including key position affected, names, reasons for change, or any financial metrics are NOT_DISCLOSED.

24-02-2026

Eva Live Inc filed an 8-K on February 24, 2026, reporting under Item 1.01 entry into a material definitive agreement, Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement, Item 3.02 unregistered sales of equity securities, and Item 9.01 financial statements and exhibits. No specific transaction values, share counts, financial metrics, or strategic details are disclosed in the provided filing summary. This multi-item disclosure indicates potentially significant corporate developments but lacks quantitative or qualitative context for impact assessment.

24-02-2026

Navitas Semiconductor Corp filed an 8-K on February 24, 2026 (AccNo: 0001104659-26-019220), disclosing information under Item 5.02 related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for change, timing, or any financial metrics are disclosed. Sector is not specified.

24-02-2026

SPACSphere Acquisition Corp. filed an 8-K on 2026-02-24 under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits), announcing events related to a merger/acquisition. No specific deal terms, parties, valuations, financial metrics, synergies, regulatory pathways, or shareholder impacts were disclosed. No quantitative data, period-over-period comparisons, or scheduled events were mentioned.